Ocrelizumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ocrelizumab. Educational only — not medical advice.
Labeled uses
OCREVUS is indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults Relapsing-remitting MS, in pediatric patients 10 years of age and older who weigh 25 kg or more.
Source: FDA labeling via NIH DailyMed (set 9da42362…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.